I do not think a single phenylpiracetam study settles anything, but the aggregate is more interesting than any individual paper.
If you need three other compounds to notice the first one, you have not tested the first one.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What the racetam class does pharmacologically does not require the subjective effect to be large to be real.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Same here.
Stupid question: how do you know whether what is in the vial matches the label at all?
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid. Eight months in on phenylpiracetam and it lines up.
Same here.
How long have you been on phenylpiracetam?
Same here.
Currently on phenylpiracetam myself.
Sleep, food, or the compound? Yes.
Loose evidence and no evidence are different, and people overcorrect in both directions. Eight months in on phenylpiracetam and it lines up.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Cold storage, light protection, date on the vial. Boring, removes half the variables. Eight months in on phenylpiracetam and it lines up.